PIL - Anastrozole 1mg Film-coated Tablets: Change history
View Patient Information Leaflet (PIL - Anastrozole 1mg Film-coated Tablets)
Last updated on this site: 23 Jul 2025
To update section 4.8 of the SmPC in line with PSUSA/00000210/202408. Consequently, the PIL has been updated.
Last updated on this site: 23 Jul 2025
To update section 4.8 of the SmPC in line with PSUSA/00000210/202408. Consequently, the PIL has been updated.
-
Changes: (Updated: 23 Jul 2025)
To update section 4.8 of the SmPC in line with PSUSA/00000210/202408. Consequently, the PIL has been updated.
-
Changes: (Updated: 23 Jul 2025)
To update section 4.8 of the SmPC in line with PSUSA/00000210/202408 for inclusion of Adverse Events Dry eye, Lichenoid eruption, Tendonitis/Tendon rupture and Memory impairment. Consequently, the PIL has been updated.
-
Changes: (Updated: 09 Nov 2023)
Description of update: Repurposing project to add indication Primary prevention of breast cancer in postmenopausal women at moderate or high risk. Supported by IBIS-II study and sponsored by NHS. Updates to SmPC sections 4.1, 4.2, 4.4, 4.8(ADR), and 5.1. Consequential updates to the PIL and RMP.
PIL sections updated: Heading, index, 1, 2, 3, 4, 5 and 6.
-
Changes: (Updated: 20 Sep 2022)
Linked to amended product entry
-
Changes: (Updated: 15 Sep 2022)
Initial upload
-
Changes: (Updated: 15 Sep 2022)
initial upload